Immunology. Richard Coico
use scFv‐based receptor. First ...
19 Chapter 19Figure 19.1. Parabolic curve of the damage‐response framework. The y axis de...Figure 19.2. Potential outcomes of the interaction between a host and a micr...Figure 19.3. The relationship between the primary and secondary immune respo...Figure 19.4. Concentration of immunoglobulin in the serum during human devel...Figure 19.5. Serum concentration of human and equine IgG antitoxin following...Figure 19.6. The fate of human and equine IgG following administration into ...
20 Chapter 20Figure 20.1. Amount of label bound to antibody after incubation of constant ...Figure 20.2. Radioimmunoassay, based on the competition of nonlabeled and la...Figure 20.3. A representative ELISA using a well coated directly with antige...Figure 20.4. A schematic representation of a fluorescence‐activated cell sor...Figure 20.5. A schematic representation of the production of monoclonal anti...Figure 20.6. Assessment of apoptosis using a TUNEL assay.Figure 20.7. Tunel apoptosis assay. Cervical cancer cells (HeLA) grown in ce...Figure 20.8. A general procedure for producing transgenic mice.Figure 20.9. Microarray assay comparing samples of mRNA from lymphoid tumor ...
Guide
1 COVER
2 TABLE OF CONTENTS
Pages
1 iii
2 iv
3 v
4 x
5 xi
6 xii
7 xiii
8 xiv
9 xv
10 xvi
11 1
12 2
13 3
14 4
15 5
16 6
17 7
18 8
19 9
20 10
21 11
22 12
23 13
24 14
25 15
26 16
27 17
28 18
29 19
30 20
31 21
32 22
33 23
34 24
35 25
36 26
37 27
38 28
39 29
40 30
41 31
42 32
43 33
44 34
45 35
46 36
47 37
48 38
49 39
50 40
51 41
52 42
53 43